Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals, a specialty biopharmaceutical company stated, “Our company is committed to forming partnerships and broadening the services offered to patients with narcolepsy. The Narcolepsy CareLine is a great example of how two organizations can come together on behalf of patients.”No, this is another fine example of your morally bankrupt company taking advantage of a "Patient's Advocacy" organization and it's good name to not only refer naive and unsuspecting patients to doctors who are predisposed to prescribe your outrageously expensive poison, but also facilitate the insurance reimbursement of those government protected and taxpayer subsidised orphan drug prices. (see also: Narcolepsy Network)
This is your way of making sure that you continue to sell Xyrem whether it helps us or not.
Nice Try.
My response is coming Monday.
